GRPR and breast carcinoma: Several clinical pilot studies have illustrated, in vivo, the potential of GRP-R for breast cancer imaging using radiolabelled GRP-R antagonists such as 68Ga-SB3, 68Ga-RM2 or 68Ga-NOTA-RM26 [4,5,6].